4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-26-166822
Director sold 337,248 shares at an average $20.21 ($6,815,190)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kersten Dirk · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-17 | Sale : show line 1 in the form 10b5-1 | −211,974 | $20.29 | $4,301,292 | 4,332,799 | I |
| 2026-04-20 | Sale : show line 2 in the form 10b5-1 | −125,274 | $20.07 | $2,513,898 | 4,207,525 | I |
| Open-market sales · 337,248 sh · avg $20.21 · $6,815,190 | ||||||
Loading xslF345X06/ownership.xml…